VKTX VIKING THERAPEUTICS INC US FDA Inspections 8-K Filing 2024 - Results Announcement Viking Therapeutics, Inc. announced results from its Phase 2b VOYAGE study of VK2809.Get access to all SEC 8-K filings of the VIKING THERAPEUTICS INC